Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.

Myrthe J van Dijk Minke A E RabBrigitte A van OirschotJennifer BosCleo DerichsAnita W RijneveldMarjon H Cnossen Erfan Nur Bart J Biemond Marije Bartels Judith J M Jans Wouter W van Solinge Roger E G Schutgens Richard van Wijk Eduard J van Beers

Published in: American journal of hematology (2022)

Keyphrases